SciTransfer
ProACT · Project

Home Care Platform That Connects Patients with Multiple Chronic Diseases to Their Care Teams

healthPilotedTRL 6

Imagine someone with diabetes, heart problems, and early memory issues trying to manage all three conditions at home — different doctors, different devices, different apps, none of them talking to each other. ProACT built a single digital platform that pulls all that health data together in one place, so the patient, their family, and their care team can all see what's happening in real time. It was tested with 120 real patients in Ireland and Belgium. Think of it like a shared dashboard for everyone involved in keeping a person healthy at home.

By the numbers
50 million
Multimorbid patients in Europe targeted by this solution
€700 billion
Annual EU cost of chronic disease management
120
Patients in proof of concept trials
4
Models of care/support examined
14
Consortium partners
7
Countries represented in consortium
3
Progressive software releases delivered
The business problem

What needed solving

Managing patients with multiple chronic diseases at home is fragmented and expensive — different devices, different apps, different doctors, none connected. Europe spends €700 billion annually on chronic disease management for 50 million multimorbid patients, much of it on avoidable hospital visits that better home monitoring could prevent.

The solution

What was built

ProACT delivered a cloud-based integrated care platform with an open API, three progressive software releases (test, trial, and final deployment version), and validated it through proof of concept trials with 120 patients in Ireland and Belgium. The platform covers heart failure, diabetes, COPD, and early dementia detection.

Audience

Who needs this

Large home care providers managing patients with multiple chronic conditionsHealth tech companies wanting to integrate their devices into a broader care ecosystemHealth insurers and managed care organizations looking to reduce chronic disease costsNational health services planning digital transformation of community careAssisted living facility operators seeking connected patient monitoring
Business applications

Who can put this to work

Home Healthcare Services
enterprise
Target: Home care providers and community nursing organizations

If you are a home care provider struggling to coordinate services for patients who have multiple chronic conditions — this project developed an integrated cloud platform that connects patient devices, care teams, and family members into one ecosystem. It was tested with 120 patients across health services in Ireland and Belgium, covering heart failure, diabetes, COPD, and early dementia. The final software release was designed for use beyond the project timeframe.

Health Technology / MedTech
any
Target: Companies developing remote patient monitoring devices or chronic disease management apps

If you are a health tech company whose devices or apps work in isolation from other care tools — this project created an open API that lets different technologies plug into a shared care platform. It integrates clinical status information, therapy tools, and activity monitors for conditions like diabetes, heart failure, and COPD. With 14 partners including 2 major ICT companies already involved, the architecture is built for third-party integration.

Health Insurance and Managed Care
enterprise
Target: Insurance companies and health funds managing chronic disease costs

If you are a health insurer facing rising costs from Europe's 50 million multimorbid patients — this project built cloud-based analytics that measure the relationship between technology use, care network support, and patient outcomes. The platform enables comparison of efficiency and costs across 4 models of care. It was validated with a European feasibility study assessing cultural and political factors for adoption and scalability.

Frequently asked

Quick answers

What would it cost to deploy this platform in our organization?

The project data does not include specific licensing fees or deployment costs. The platform was built as an open API ecosystem with cloud-based infrastructure, which typically means subscription-based pricing. Contact the consortium through Trinity College Dublin for commercial terms.

Can this scale beyond a 120-patient trial to thousands of users?

The project included a European feasibility study specifically to assess cultural and political determinants for adoption and scalability. The platform was designed with cloud architecture and an open API, which supports scaling. However, clinical validation at larger scale would likely be needed before full rollout.

Who owns the IP and can we license this technology?

The project was coordinated by Trinity College Dublin with 14 partners across 7 countries. IP is likely shared among consortium members under the Horizon 2020 grant agreement. The consortium included 9 private organizations, suggesting commercial licensing was anticipated. Contact the coordinator for licensing arrangements.

Which chronic conditions does the platform support?

The platform was specifically developed and tested for chronic heart failure, diabetes, and chronic obstructive pulmonary disease (COPD). It also includes tools to support mild cognitive impairment and detect early onset dementia. These cover some of the most expensive chronic conditions in Europe.

How does this integrate with our existing hospital or care IT systems?

ProACT was built around an open API specifically designed to integrate new and existing technologies. The platform aggregates data from various devices and tools into a cloud-based system. Three progressive software releases were produced, with the final version designed for use beyond the project timeframe.

What evidence exists that this actually improves patient outcomes?

Proof of concept trials were conducted with 120 patients in Health Services in Ireland and Belgium, using associated living lab facilities to ensure patient co-design. The cloud analytics were designed to determine correlations between technology use and impact on health and quality of life. Based on available project data, detailed clinical outcome results would need to be requested from the consortium.

Is this compliant with EU health data regulations?

Based on available project data, the project ran clinical trials within official Health Services in Ireland and Belgium, which would require ethics approval and data protection compliance. The project operated under Horizon 2020 rules during 2016-2019. Current GDPR and Medical Device Regulation compliance should be verified with the consortium.

Consortium

Who built it

The ProACT consortium is notably industry-heavy for a health research project: 6 out of 14 partners are industry players (43%), including what the project describes as 2 of the world's leading ICT companies and the largest home care provider. Three partners are SMEs. With 3 universities and 1 research organization providing the clinical and technical backbone, and 4 other organizations (likely patient groups and service networks), this consortium was clearly built with commercialization in mind. The spread across 7 countries (Austria, Belgium, Spain, Ireland, Italy, Netherlands, UK) gives it a European market perspective, while the proof of concept trials in Irish and Belgian health services provide real-world validation from two different healthcare systems.

How to reach the team

Coordinated by Trinity College Dublin (Ireland). Reach the research team through Trinity's CASALA (Centre for Affective Solutions for Ambient Living Awareness) or the university's technology transfer office.

Next steps

Talk to the team behind this work.

Want to explore licensing or deploying the ProACT platform in your care organization? SciTransfer can connect you directly with the development team and help structure a pilot agreement.

More in Health & Biomedical
See all Health & Biomedical projects